Lilly: Vendors key after Zyprexa patent loss
Lilly’s patent-loss challenges—the biggest of which takes effect today—will force the company to rely even more on its 1,300 Indiana vendors.
Lilly’s patent-loss challenges—the biggest of which takes effect today—will force the company to rely even more on its 1,300 Indiana vendors.
Cigna Corp. will buy fellow health insurer HealthSpring Inc. in a $3.8 billion deal as it becomes the latest managed care company to snap up a bigger share of the fast-growing Medicare Advantage market.
As constitutional challenges to the health reform law’s mandate to buy insurance advance, WellPoint Inc.’s chief financial officer reiterated that the company does not object to the mandate, just to its lack of penalties.
The hospitals owned by Boone and Hamilton counties are following the lead of Indianapolis-based Wishard Health Services and its parent organization by acquiring far-flung nursing homes, hoping the strategy proves as lucrative.
The Indianapolis-based drugmaker earned $1.24 billion in the three months ended Sept. 30, down 5 percent from the same quarter a year ago, even as revenue surged 9 percent.
Eli Lilly and Co. and Amylin Pharmaceuticals Inc.’s Byetta has received expanded approval for use with the world’s top-selling insulin to treat Type 2 diabetes.
Kexue Huang faces up to 13 years in prison after pleading guilty Tuesday morning to sending trade secrets worth millions to China and Germany.
The Indiana Court of Appeals reversed a Marion Superior Court decision to dismiss a lawsuit by two uninsured patients who received care at IU Health North Hospital in Carmel.
Medicare supplement policies are reportedly one of the targets of Congress’ special deficit-reduction committee—and that’s not good news for Carmel-based CNO Financial Group Inc.
An IU official said premiums continue to rise and the university can't continue matching the amount of the increase.
The device would be the first drug-coated stent approved in the U.S. to treat peripheral vascular disease in the largest artery of the upper leg.
The company saw sales surge after introducing software in May that helps medical labs manage their disparate computer systems from a Web portal.
Peripheral vascular devices, including stents, angioplasty balloons and synthetic grafts, generated $4.3 billion in global revenue last year and may earn $5.6 billion in 2014.
Bryce Carmine, president of Lilly’s bio-medicines division, and Frank Deane, president of Lilly’s global manufacturing operations, both will retire on Dec. 31.
Remaining grant money will be invested to beef up the infrastructure of the Indiana Network for Patient Care, a health information exchange operated by the Indianapolis-based Regenstrief Institute.
Eli Lilly and Co. got called out in a recent report on companies that took advantage of the 2004 tax holiday on foreign profits and have since slashed jobs.
Medical residents are getting more job offers than before, yet greater numbers of them say if they had it to do over again, they would not go to medical school.
Cialis, Lilly’s blockbuster erectile dysfunction drug, now can be taken to treat enlarged prostate. FDA approval means men who suffer from both disorders can take one medication.
When Jeanette Sabir-Holloway entered dental school at Indiana University in 1976, she was one of only three black students in a class of 120. She would be the only African-American to graduate with her class four years later.